About us
Innovative Approach
Our revolutionary approach combines early diagnosis and a new treatment concept. This will prevent current and future generations from suffering from Alzheimer’s.
The Immungenetics drug challenge leverages a causative disease mechanism to diagnose pre-clinical AD.
Our drug improves Aβ monomer clearance and restores the autophagic flux, a mechanism essential for the removal of Aβ and Tau aggregates.
To learn more, please contact us.
About us
Innovative Approach
Our revolutionary approach combines early diagnosis and a new treatment concept. This will prevent current and future generations from suffering from Alzheimer’s.
The Immungenetics drug challenge leverages a causative disease mechanism to diagnose pre-clinical AD.
Our drug improves Aβ monomer clearance and restores the autophagic flux, a mechanism essential for the removal of Aβ and Tau aggregates.
To learn more, please contact us.
Clinical
Development
